| 序号 | 产品名称 | 产品数量 |
| 1 | 1835705-55-9 | 5 |
| 2 | cis-[Pt(NH3)2-(phenanthridine)Cl]NO3 | 1 |
| 3 | 57938-82-6 | 1 |
| 4 | (S,R,S)-AHPC-C3-NH2(VH032-C3-NH2) | 1 |
| 5 | 60696-62-0 | 3 |
| 6 | 9-Isopropylolomoucine | 1 |
| 7 | 2245697-83-8 | 5 |
| 8 | 4-Desmethyldecaline | 1 |
| 9 | (S,R,S)-AHPC-(C3-PEG)2-C6-Cl | 4 |
| 10 | DRG-0182 | 1 |
| 11 | DRG0182 | 1 |
| 12 | Nocodazole(Oncodazole R17934) | 1 |
| 13 | 1835705-61-7 | 5 |
| 14 | (S,R,S)-AHPC hydrochloride(MDK7526 hydrochlorideVH032-NH2 hydrochloride) | 1 |
| 15 | β-Glycerol phosphate disodium salt pentahydrate [CAS 13408-09-8] | 1 |
| 16 | VO-Ohpic trihydrate(VO-Ohpic) | 1 |
| 17 | SF1670(PTPase CD45 Inhibitor) | 1 |
| 18 | ALK-01-040 | 1 |
| 19 | Receptor-mediated permeabiliser-7 | 1 |
| 20 | (vic)-Trastuzumab duocarmazine | 1 |
| 21 | PI4KIIIbeta inhibitor 9 | 1 |
| 22 | Trastuzumab duocarmazine | 1 |
| 23 | 16858-02-9 | 8 |
| 24 | 布帕尼西盐酸盐 | 1 |
| 25 | Buparlisib Hydrochloride(BKM120 Hydrochloride NVP-BKM120 Hydrochloride) | 1 |
| 26 | MP7 | 4 |
| 27 | RMP-7 | 1 |
| 28 | 404-86-4 | 9 |
| 29 | (S)-(-)-Pantoprazole sodium | 1 |
| 30 | GDC-0980(ApitolisibGNE 390RG 7422) | 1 |
| 31 | Everolimus(RAD001 SDZ-RAD) | 1 |
| 32 | ABT-751(E 7010) | 1 |
| 33 | Src Kinase Inhibitor 1 | 3 |
| 34 | Troparil | 1 |
| 35 | 抗氧化剂 TH-1790 | 1 |
| 36 | Dihydromyricetin(AmpeloptinAmpelopsin) | 1 |
| 37 | Deforolimus(AP23573MK-8669Ridaforolimus) | 1 |
| 38 | 1642152-40-6 | 1 |
| 39 | DRG 0182 | 1 |
| 40 | huC242-DM4 | 1 |
| 41 | 606-68-8 | 9 |
| 42 | AR-A014418, ARA 014418, ARA014418 | 1 |
| 43 | 487-21-8 | 3 |
| 44 | RGB-286638 free base(RGB286638 free base) | 1 |
| 45 | 74163-84-1 | 1 |
| 46 | Tolebrutinib(SAR-442168) | 1 |
| 47 | UNII-S1JX147O5E | 1 |
| 48 | 肯帕罗酮 | 1 |
| 49 | 94-25-7 | 8 |
| 50 | Kenpaullone(9-BromopaulloneNSC-664704) | 1 |
| 51 | 1107-26-2 | 3 |
| 52 | Indirubin-3'-monoxime(Indirubin-3'-oxime) | 1 |
| 53 | 623-05-2 | 8 |
| 54 | CP21R7(CP21) | 1 |
| 55 | IMGN242 | 1 |
| 56 | Cantuzumab ravtansine | 1 |
| 57 | Mitoxana | 1 |
| 58 | Moiramide B | 2 |
| 59 | CHIR-99021 trihydrochloride(Laduviglusib CHIR99021 CT99021 trihydrochloride) | 1 |
| 60 | Epothilone B(EPO 906 Patupilone) | 1 |
| 61 | CHIR-99021 monohydrochloride(Laduviglusib CHIR99021 CT99021 monohydrochloride) | 1 |
| 62 | CHIR-99021(Laduviglusib CHIR99021 CT99021) | 1 |
| 63 | 1268163-15-0 | 1 |
| 64 | 9-hydroxyellipticine HCl | 1 |
| 65 | L-67, L 67 | 1 |
| 66 | AR-A014418(AR 0133418GSK 3βinhibitorAR 014418) | 1 |
| 67 | SAMS(His-Met-Arg-Ser-Ala-Met-Ser-Gly-Leu-His-Leu-Val-Lys-Arg-Arg-NH2) | 1 |
| 68 | Crosstide(Gly-Arg-Pro-Arg-Thr-Ser-Ser-Phe-Ala-Glu-GlyGRPRTSSFAEG) | 1 |
| 69 | Vincristine sulfate(Leurocristine) | 1 |
| 70 | Capivasertib(AZD5363) | 1 |
| 71 | Docetaxel(RP 56976) | 1 |
| 72 | (+)-Ifosfamide | 1 |
| 73 | NSC 407347 | 1 |
| 74 | 155233-31-1 | 2 |
| 75 | 2133-40-6 | 2 |
| 76 | Cyclo(RGDyK)TFA | 1 |
| 77 | APE1-IN-1 | 1 |
| 78 | Akt1/2 inhibitor 1 | 1 |
| 79 | Tirofiban(L700462 MK383) | 1 |
| 80 | 524708-03-0 | 1 |
| 81 | AKT inhibitor 1 | 1 |
| 82 | JR-14a | 1 |
| 83 | Afuresertib hydrochloride(GSK2110183 hydrochloride) | 1 |
| 84 | 868747-45-9 | 1 |
| 85 | Afuresertib(GSK2110183C) | 1 |
| 86 | RGD(Arg-Gly-Asp) | 2 |
| 87 | Cilengitide TFA(EMD 121974) | 1 |
| 88 | Acalisib(GS-9820CAL-120) | 1 |
| 89 | 740 Y-P(740YPDGFRPDGFR 740Y-P) | 1 |
| 90 | 54422-29-6 | 1 |
| 91 | 54-16-0 | 5 |
| 92 | 1,3-二咖啡酰奎宁酸 | 3 |
| 93 | 1,3-Dicaffeoylquinic acid(1,3-O-Dicaffeoylquinic acid 1,5-Dicaffeoylquinic acid) | 1 |
| 94 | 2411440-41-8 | 4 |
| 95 | 52238-35-4 | 4 |
| 96 | 9-Hydroxyellipticin free base | 1 |
| 97 | NS-1619, NS 1619 | 1 |
| 98 | MEDI0382 | 1 |
| 99 | Mdivi-1(Mitochondrial division inhibitor 1) | 2 |
| 100 | 56-54-2 | 7 |
m.cnreagent.com